JP2004521950A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004521950A5 JP2004521950A5 JP2003511816A JP2003511816A JP2004521950A5 JP 2004521950 A5 JP2004521950 A5 JP 2004521950A5 JP 2003511816 A JP2003511816 A JP 2003511816A JP 2003511816 A JP2003511816 A JP 2003511816A JP 2004521950 A5 JP2004521950 A5 JP 2004521950A5
- Authority
- JP
- Japan
- Prior art keywords
- aerosol formulation
- appetite
- loss
- mammal
- pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000443 aerosol Substances 0.000 claims 17
- 238000009472 formulation Methods 0.000 claims 14
- 239000000203 mixture Substances 0.000 claims 14
- 238000000034 method Methods 0.000 claims 7
- 208000024891 symptom Diseases 0.000 claims 7
- 241000124008 Mammalia Species 0.000 claims 6
- 208000002193 Pain Diseases 0.000 claims 6
- 230000004596 appetite loss Effects 0.000 claims 6
- 208000019017 loss of appetite Diseases 0.000 claims 6
- 235000021266 loss of appetite Nutrition 0.000 claims 6
- 230000036407 pain Effects 0.000 claims 6
- HCAWPGARWVBULJ-IAGOWNOFSA-N delta8-THC Chemical compound C1C(C)=CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 HCAWPGARWVBULJ-IAGOWNOFSA-N 0.000 claims 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- 206010028813 Nausea Diseases 0.000 claims 4
- 206010047700 Vomiting Diseases 0.000 claims 4
- 230000008693 nausea Effects 0.000 claims 4
- 239000003380 propellant Substances 0.000 claims 4
- 230000008673 vomiting Effects 0.000 claims 4
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical group FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 208000004983 Phantom Limb Diseases 0.000 claims 2
- 208000022531 anorexia Diseases 0.000 claims 2
- 208000006673 asthma Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 238000002512 chemotherapy Methods 0.000 claims 2
- 206010061428 decreased appetite Diseases 0.000 claims 2
- 210000004072 lung Anatomy 0.000 claims 2
- 201000006417 multiple sclerosis Diseases 0.000 claims 2
- 210000002850 nasal mucosa Anatomy 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- YFMFNYKEUDLDTL-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical compound FC(F)(F)C(F)C(F)(F)F YFMFNYKEUDLDTL-UHFFFAOYSA-N 0.000 claims 1
- 210000005178 buccal mucosa Anatomy 0.000 claims 1
- UKACHOXRXFQJFN-UHFFFAOYSA-N heptafluoropropane Chemical compound FC(F)C(F)(F)C(F)(F)F UKACHOXRXFQJFN-UHFFFAOYSA-N 0.000 claims 1
- 229940071648 metered dose inhaler Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30502101P | 2001-07-10 | 2001-07-10 | |
| PCT/GB2002/003161 WO2003006010A1 (en) | 2001-07-10 | 2002-07-10 | Aerosol formulations of δ8 tetrahydrocannabinol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004521950A JP2004521950A (ja) | 2004-07-22 |
| JP2004521950A5 true JP2004521950A5 (https=) | 2006-01-05 |
Family
ID=23178964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003511816A Pending JP2004521950A (ja) | 2001-07-10 | 2002-07-10 | Δ８テトラヒドロカンナビノールのエアロゾル製剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050079136A1 (https=) |
| EP (1) | EP1404314A1 (https=) |
| JP (1) | JP2004521950A (https=) |
| KR (1) | KR20040032851A (https=) |
| AU (1) | AU2002319422C1 (https=) |
| CA (1) | CA2453389A1 (https=) |
| WO (1) | WO2003006010A1 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1361864T3 (en) * | 2001-02-14 | 2014-03-03 | Gw Pharma Ltd | FLYLDENDE SPRAY FORMULATIONS FOR buccal administration of cannabinoids |
| US20040248970A1 (en) * | 2003-04-10 | 2004-12-09 | Webster G.R. Barrie | CBD-delta8-THC composition |
| EP1855666A1 (en) * | 2005-02-25 | 2007-11-21 | Unimed Pharmaceuticals, Inc. | Dronabinol compositions and methods of using same |
| US20070060639A1 (en) * | 2005-09-09 | 2007-03-15 | University Of Kentucky | Compositions and methods for intranasal delivery of tricyclic cannabinoids |
| US8039509B2 (en) | 2006-11-10 | 2011-10-18 | Johnson Matthey Public Limited Company | Composition comprising (−)-Δ9-trans-tetrahydrocannabinol |
| US8980940B2 (en) | 2006-11-10 | 2015-03-17 | Johnson Matthey Public Limited Company | Stable cannabinoid compositions and methods for making and storing them |
| US8222292B2 (en) | 2007-08-06 | 2012-07-17 | Insys Therapeutics, Inc. | Liquid cannabinoid formulations |
| DE102007063210A1 (de) * | 2007-12-20 | 2009-06-25 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Arzneimittel zur Behandlung von Phantomphänomenen |
| US12496271B2 (en) | 2019-02-22 | 2025-12-16 | Benuvia Operations, Llc | Oral cannabinoid formulations |
| US9345771B2 (en) | 2012-10-04 | 2016-05-24 | Insys Development Company, Inc. | Oral cannabinoid formulations |
| US11253472B2 (en) | 2012-10-04 | 2022-02-22 | Benuvia Therapeutics Llc | Oral cannabinoid formulations |
| US10265293B2 (en) | 2012-10-04 | 2019-04-23 | Insys Development Company, Inc. | Oral cannabinoid formulations |
| US9095563B2 (en) | 2013-09-26 | 2015-08-04 | Ronald D. Sekura | Topical treatments incorporating Cannabis sp. derived botanical drug product |
| US20160151275A1 (en) * | 2014-06-16 | 2016-06-02 | James Kevin Shurtleff | Method and devices for manufacturing and delivering of aerosolized formulations |
| EP3160445B1 (en) | 2014-06-26 | 2021-10-20 | Island Breeze Systems Ca, LLC | Mdi related products and methods of use |
| AU2015308546A1 (en) | 2014-08-25 | 2017-04-13 | Clk Consult V/ Carsten Leonhard Knudsen | Device with compositions for delivery to the lungs, the oral mucosa and the brain |
| US9717683B1 (en) | 2016-06-29 | 2017-08-01 | Ep Pharma, Llc | Low-temperature inhalation administration of cannabinoid entities |
| US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
| US10231948B2 (en) | 2017-02-27 | 2019-03-19 | Jason Ty Nguyen | Metered dose inhaler compositions, systems, and methods |
| CA3089994A1 (en) | 2018-01-31 | 2019-08-08 | Canopy Holdings, LLC | Hemp powder |
| WO2020077153A1 (en) | 2018-10-10 | 2020-04-16 | Canopy Holdings, LLC | Synthesis of cannabigerol |
| US20200352191A1 (en) * | 2019-05-06 | 2020-11-12 | Karl Lonsbery | Edible formulations and uses thereof |
| US11806645B1 (en) | 2019-05-07 | 2023-11-07 | Cannaceutical Extractions LLC | Methods of producing CBD/THC oils |
| WO2021071967A1 (en) * | 2019-10-09 | 2021-04-15 | Island Breeze Systems Ca, Llc | Compositions for pulmonary delivery of cannabinoids and associated methods and systems |
| US20220387352A1 (en) * | 2020-07-29 | 2022-12-08 | Medterra Pharma Llc | Cannabinoid compositions and methods of using for the treatment of non-eosinophilic inflammation and inflammatory disorders |
| US20230131989A1 (en) * | 2020-07-29 | 2023-04-27 | Medterra Pharma Llc | Cannabinoid compositions and methods of using for the treatment of non-eosinophilic inflammation and inflammatory disorders |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4803978A (en) * | 1985-08-09 | 1989-02-14 | Johnson Iv John J | Apparatus for actuating an inhaler |
| IL99468A (en) * | 1991-09-12 | 1997-09-30 | Yissum Res Dev Co | (3s, 4s)-delta- 6-tetrahydrocannabinol- 7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them |
| IL102082A (en) * | 1992-06-02 | 1997-07-13 | Yissum Res Dev Co | Antiemetic composition containing a cannabinol derivative |
| GB9726916D0 (en) * | 1997-12-19 | 1998-02-18 | Danbiosyst Uk | Nasal formulation |
| US6509005B1 (en) * | 1998-10-27 | 2003-01-21 | Virginia Commonwealth University | Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler |
| JP2003504321A (ja) * | 1999-07-08 | 2003-02-04 | オーランド・ハン | リポソーム被包カンナビノイドの肺送達 |
-
2002
- 2002-07-10 EP EP02749007A patent/EP1404314A1/en not_active Withdrawn
- 2002-07-10 CA CA002453389A patent/CA2453389A1/en not_active Abandoned
- 2002-07-10 WO PCT/GB2002/003161 patent/WO2003006010A1/en not_active Ceased
- 2002-07-10 JP JP2003511816A patent/JP2004521950A/ja active Pending
- 2002-07-10 AU AU2002319422A patent/AU2002319422C1/en not_active Ceased
- 2002-07-10 KR KR10-2004-7000415A patent/KR20040032851A/ko not_active Ceased
- 2002-07-10 US US10/483,655 patent/US20050079136A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004521950A5 (https=) | ||
| ES2745064T3 (es) | Formulación superfina de formoterol | |
| JP2005539046A (ja) | 特異的な抗コリン作用薬、β−２アゴニスト、および副腎皮質ステロイドを含む、治療薬および組成物 | |
| US20040235807A1 (en) | Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea | |
| HRP20130835T1 (hr) | Farmaceutske formulacije otopine za davanje kao stlaäśeni inhalat u inhalatoru | |
| JP2004521950A (ja) | Δ８テトラヒドロカンナビノールのエアロゾル製剤 | |
| WO2011136754A1 (en) | A medicament developed for the treatment of respiratory diseases | |
| AU2002319422A1 (en) | Aerosol formulations of delta8 tetrahydrocannabinol | |
| Woodcock et al. | Modulite® technology: pharmacodynamic and pharmacokinetic implications | |
| WO2011136753A1 (en) | Combination of carmoterol and fluticasone for use in the treatment respiratory diseases | |
| US20100136121A1 (en) | Medicaments | |
| Everard et al. | In vitro assessment of drug delivery through an endotracheal tube using a dry powder inhaler delivery system. | |
| Zainudin | Therapeutic Aerosol Principles and Practices | |
| Shah | AEROSOL BRONCHODILATORS-PRACTICAL CONSIDERATIONS |